10.01.2015 Views

Here - Stiftung Forschung 3R

Here - Stiftung Forschung 3R

Here - Stiftung Forschung 3R

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

defined and published in the form of a<br />

position paper (Van der Burg et al., 2011).<br />

The work in WP1 started with the<br />

establishment and selection of in silico<br />

pre-screening methods to categorise<br />

chemicals, using (quantitative) structureactivity<br />

relationships (Q)SARs. This will be<br />

done for major classes of toxicity prioritised<br />

in REACH (carcinogenesis, mutagenesis<br />

and reproductive (CMR) toxicity and<br />

persistent, (very) bioaccumulative toxic<br />

(PBT/vPvB) compounds). With this we<br />

prioritise further in silico/in vitro toxicity<br />

testing. As a starting point, we are using<br />

a unique database which comprises<br />

abbreviated predictions from more than 70<br />

(Q)SAR models on endpoints for physicochemical<br />

properties, fate, eco-toxicity,<br />

absorption, metabolism and toxicity. A<br />

methodology that alerts for potential<br />

reproductive toxicity will be developed<br />

and integrated all into one module, a<br />

fast and efficient toxicity screening tool<br />

will be generated based on available in<br />

silico techniques, mostly QSARs that can<br />

identify toxicological profiles that will drive<br />

the risk assessment of the chemical, e.g.,<br />

mutagenic, genotoxic carcinogenic, or<br />

endocrine-active properties.<br />

WP2 focussed on expansion of two different<br />

databases, which contain information<br />

relevant to reproductive toxicity; RepDose<br />

(repeated dose) and FeDTex (fertility and<br />

developmental toxicity). First reproductive<br />

toxicity studies were identified from peerreviewed<br />

publications, as well as other<br />

databases provided by other partners.<br />

Available studies on reproductive toxicity<br />

were selected for data entry. In particular,<br />

the amount of chemicals in FeDTex will<br />

be more than doubled in the course of<br />

ChemScreen, mounting up to over 300. A<br />

significant overlap with RepDose is created<br />

to allow comparison of in vivo data with<br />

the same chemical and evaluate possible<br />

predictivity of repeated dose toxicity for<br />

reproductive toxicity.<br />

WP2 scientists started a unique<br />

collaboration with WP3 and the NCCT on<br />

the identification of critical endpoints of<br />

reproductive toxicity using combined, in<br />

depth analysis of databases present at<br />

three different locations (i.e., Fraunhofer<br />

Institute, RIVM and NCCT). These results<br />

will become available in the next period,<br />

and will be extended to ecotoxicological<br />

endpoints using the EDUKON database<br />

present at the University of Konstanz (see<br />

WP5).<br />

The aim of WP3 is the design of a<br />

‘minimal essential’ reproductive toxicity<br />

screen, consisting of a number of in<br />

vitro assays that are representative of<br />

those parameters in reproductive toxicity<br />

that are crucial for reproductive hazard<br />

assessment. A literature survey of past<br />

experience will result in a prioritised list<br />

of parameters that need to be addressed<br />

in hazard assessment. This part of the<br />

work is ongoing. Meanwhile, progress<br />

was obtained with the optimisation and<br />

amendment to higher-throughput of two<br />

tests that are very likely to be included<br />

in the final battery, namely a genomicsbased<br />

improved embryonic stem cell test,<br />

and steroidogenesis assays. In addition,<br />

zebrafish early life stage tests and oocyte<br />

maturation/fertilisation tests are being<br />

66 PROGRESS REPORTS FROM EU-FUNDED PROJECTS<br />

Progress Report 2011 & AXLR8-2 Workshop Report

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!